Elveția - italiană - Swissmedic (Swiss Agency for Therapeutic Products)

future health pharma gmbh - calcitoninum salmonis - soluzione iniettabile - calcitoninum salmonis 100 u.i., natrii acetas trihydricus, acidum aceticum glaciale, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.29 mg. - osteoporoseprävention, morbus paget, hyperkalzämie, neurodystrophische störungen - synthetika

Elveția - italiană - Swissmedic (Swiss Agency for Therapeutic Products)

future health pharma gmbh - calcitoninum salmonis - soluzione iniettabile - calcitoninum salmonis 50 u.i., natrii acetas trihydricus, acidum aceticum glaciale, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.29 mg. - osteoporoseprävention, morbus paget, hyperkalzämie, neurodystrophische störungen - synthetika

Elveția - italiană - Swissmedic (Swiss Agency for Therapeutic Products)

future health pharma gmbh - indometacinum - capsule - indometacinum 75 mg, saccharum 102.29 mg, maydis amylum, cellulosum microcristallinum, hypromellosum, magnesii stearas, poly(vinylis acetas), e 132, kapselhülle: gelatina, e 171, e 172 (flavum), pro capsula. - antirheumaticum - synthetika

Elveția - italiană - Swissmedic (Swiss Agency for Therapeutic Products)

future health pharma gmbh - estradiolum hemihydricum, norethisteroni acetas - cerotti transdermici - estradiolum hemihydricum 3.2 mg, norethisteroni acetas 11.2 mg, excipiens per la preparazione per il 16 cm2 con la liberazione di 50 µg e 170 µg/24 h. - estrogeno-progestinici terapia sostitutiva dopo la menopausa - synthetika

Elveția - italiană - Swissmedic (Swiss Agency for Therapeutic Products)

future health pharma gmbh - estradiolum hemihydricum, norethisteroni acetas - cerotti transdermici (kombipackung) - i) fase i pflaster: estradiolum hemihydricum 3.2 mg, excipiens per la preparazione per il 16 cm2 con la liberazione di 50 µg/24 h. ii) fase ii pflaster: estradiolum hemihydricum 3.2 mg, norethisteroni acetas 11.2 mg, excipiens per la preparazione per il 16 cm2 con la liberazione di 50 µg e 170 µg/24 h. - estrogeno-progestinici terapia sostitutiva dopo la menopausa - synthetika

Elveția - italiană - Swissmedic (Swiss Agency for Therapeutic Products)

future health pharma gmbh - natrii risedronas - compresse rivestite con film - natrii risedronas 30.0 mg corresp. natrium 2.26 mg, lactosum monohydricum 131.0 mg, cellulosum microcristallinum, crospovidonum, magnesii stearas, Überzug: hypromellosum, macrogolum 400, hydroxypropylcellulosum, macrogolum 8000, silica colloidalis anhydrica, e 171, pro compresso obducto. - osteoporose, paget-krankheit - synthetika

Elveția - italiană - Swissmedic (Swiss Agency for Therapeutic Products)

future health pharma gmbh - natrii risedronas - compresse rivestite con film - natrii risedronas 35.0 mg corresp. natrium 2.64 mg, lactosum monohydricum 126.0 mg, cellulosum microcristallinum, crospovidonum, magnesii stearas, Überzug: hypromellosum, macrogolum 400, hydroxypropylcellulosum, macrogolum 8000, silica colloidalis anhydrica, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - osteoporose, paget-krankheit - synthetika

Elveția - italiană - Swissmedic (Swiss Agency for Therapeutic Products)

future health pharma gmbh - testosteronum - gel - testosteronum 50 mg, isopropylis myristas, ethanolum 96 per centum, carbomerum 980, natrii hydroxidum, aqua purificata ad gelatum pro 5 g. - ipogonadismo maschile - synthetika

Elveția - italiană - Swissmedic (Swiss Agency for Therapeutic Products)

future health pharma gmbh - testosteronum - gel - testosteronum 25 mg, isopropylis myristas, ethanolum 96 per centum, carbomerum 980, natrii hydroxidum, aqua purificata ad gelatum pro 2.5 g. - ipogonadismo maschile - synthetika

Elveția - italiană - Swissmedic (Swiss Agency for Therapeutic Products)

future health pharma gmbh - hexaminolaevulinatum - pulver und lösungsmittel zur herstellung einer fertigspritze zur intravesikalen anwendung - praeparatio sicca: hexaminolaevulinati hydrochloridum 100 mg corresp. hexaminolaevulinatum 85 mg pro vitro. solvens: dinatrii phosphas dihydricus, kalii dihydrogenophosphas, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile ad solutionem pro 50 ml. - kit diagnostici per la fluorescenza cistoscopia - synthetika